QUAL iShares MSCI USA Quality Factor ETF

Expense Ratio
0.15%
Dividend
0.89%
Previous close
$212.23
Est. 12 months change
+15.94%
Projected Price
$246.05

Profitability Metrics

Return on Equity (ROE)
60.92%
Return on Assets (ROA)
17.31%
Return on Invested Capital (ROIC)
49.91%
Weighted Average Cost of Capital (WACC)
10.11%
ROIC - WACC
39.80%
Updated : 2026-05-20 19:05 ET

Valuation Metrics

P/E Ratio
28.53
Forward P/E
23.49
PEG Ratio
2.34
Debt Current Ratio
2.28

Growth & Cash Flow

Gross Margin
57.24%
Operating Margin
33.69%
FCF Margin
24.59%
TTM Revenue Growth
19.88%
Projected 12M EPS Growth
21.44%

Price Change

Price % from 50 SMA
5.16%
Price % from 200 SMA
7.27%
6 Months
12.08%
1 Year
18.59%
2 Years
27.77%
The above metrics represent weighted averages, calculated using each stock's individual value weighted by its proportion of ETF holdings.

Top 10 Holdings

Stock TickerWeight
NVDA7.67%
AAPL6.88%
MSFT5.05%
LRCX3.73%
META3.53%
LLY3.14%
KLAC3.01%
V3.01%
TJX3.00%
AMAT2.73%

ETF Analysis

Fund Overview

iShares MSCI USA Quality Factor ETF (QUAL) currently reports 120 stock positions (subject to change), placing it in the broadly constructed range by holdings breadth. The top line-up is NVDA (7.67%), AAPL (6.88%), MSFT (5.05%), with NVDA as the largest single weight at 7.67%. Together, the top three holdings account for 19.60%, which suggests the fund is not overly reliant on its largest positions to generate returns. The fund's architecture positions it to benefit from strength in its top holdings while the broader basket provides a degree of insulation against single-name shocks.

Profitability & Capital Efficiency

Looking at how effectively the underlying holdings deploy capital, ROIC is 49.91%, WACC is 10.11%, and the economic spread is 39.80%. On balance, holdings are earning returns on capital well in excess of what investors and creditors require — the defining characteristic of a high-quality compounding portfolio. Supporting metrics show ROE at 60.92% and ROA at 17.31%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.

Valuation

On valuation, the portfolio registers trailing P/E of 28.53, forward P/E of 23.49, PEG of 2.34. The spread between the two P/E figures is moderate, suggesting earnings are expected to improve gradually rather than accelerate sharply. The PEG reading here implies the market is pricing growth at roughly fair value — a setup where the investment case depends more on execution than on multiple expansion. A current ratio reading of 2.28 points to holdings that are managing short-term obligations without apparent stress. Taken together, the multiple and liquidity picture suggests a portfolio that is priced for a constructive outcome — but where execution against earnings estimates will be the key determinant of whether that price is justified.

Margins & Cash Generation

Across the three margin layers, gross margin sits at 57.24%, operating margin at 33.69%, and free cash flow margin at 24.59%. Gross margins sit in a healthy range, consistent with businesses that manage input costs effectively. Operating margins this strong typically indicate a combination of pricing power, cost discipline, and operating leverage. At this level, free cash flow margins suggest businesses that are building financial strength alongside revenue growth. Read together, these margins describe businesses that have earned their profitability rather than manufactured it through accounting — a meaningful quality signal.

Growth & Forward Outlook

On a forward-looking basis, TTM revenue growth of 19.88% a signal of steady demand without the volatility of high-growth names, while the estimated 12-month price change of 16.10%, where the target distribution indicates incremental upside rather than outsized repricing. Revenue growth and price targets are correlated but not the same — strong operations do not always translate to strong price appreciation, and vice versa. The forward return case rests on whether the businesses can sustain their operating trajectory long enough for analyst price targets to be reached or exceeded. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Strong Buy

The full scorecard here is hard to argue with: capital efficiency is strong, margins are healthy, and growth is being priced constructively.

This assessment reflects quantitative metrics only and does not constitute financial advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.